Abdulla Damluji Highlights ASPREE Trial Update
Abdulla A. Damluji, Director of the Cardiovascular Center on Aging at Cleveland Clinic, has shared an insightful thread on X:
“Aspirin, cardiovascular events, and major bleeding in older adults: extended follow-up of the ASPREE trial: ESC Journals
Aspirin for primary prevention for older pts = MACE! ”
Read the full article here.
Title: Aspirin, cardiovascular events, and major bleeding in older adults: extended follow-up of the ASPREE trial
Authors: Rory Wolfe, Jonathan C Broder, Zhen Zhou, Anne M Murray, Joanne Ryan, Andrew T Chan, Mark R Nelson, Robyn L Woods, Michael E Ernst, Suzanne G Orchard, Brenda Kirpach, Christopher M Reid, Raj C Shah, Nigel Stocks, Karen L Margolis, Johannes T Neumann, Michelle Wilson, Sharyn Fitzgerald, Suzanne E Mahady, Erica M Wood, Shara Ket, Charles B Eaton, Peter Hand, Mobin Malik, Walter P Abhayaratna, Prasanna Venkataraman, Peter Chan, Geoffrey C Cloud, Geoffrey A Donnan, Jeff D Williamson, Andrew M Tonkin
Stay updated with Hemostasis Today.
-
Feb 23, 2026, 13:53Rare Diseases, Plasma-Derived Medicines and the Elephant in the Room – Part 1
-
Feb 23, 2026, 13:02Deepak Yadav: What 2025 Evidence Tells Us About Stroke Care
-
Feb 23, 2026, 12:55Radoslaw Kaczmarek: Will AAV Gene Therapy for Hemophilia Trigger Tumorigenesis?
-
Feb 23, 2026, 12:46Heghine Khachatryan: More Granular Risk Stratification Framework for PE from The New 2026 AHA/ACC Guideline
-
Feb 23, 2026, 12:37Reza Shojaei: EU’s Critical Medicines Act and Plasma Resilience
-
Feb 23, 2026, 12:32Anirban Sen Gupta: Emily Mihalko Highlights PlateChek at MTEC
-
Feb 23, 2026, 12:25Ryan Williams: Excellent Highlights on The Heterogeneity of PRP Preparation
-
Feb 23, 2026, 12:10Peter Libby: hsCRP May Select Patients Who Can Benefit From Statins or Anti-inflammatory Therapy
-
Feb 23, 2026, 12:02Marios Georgakis: An Unprecedented for An Antithrombotic Therapy from OCEANIC-STROKE Trial